NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$3.32
-0.07 (-2.06%)
Open$3.38
Previous Close$3.39
Day High$3.42
Day Low$3.31
52W High$5.06
52W Low$1.62
Volume—
Avg Volume675.6K
Market Cap146.77M
P/E Ratio—
EPS$-0.74
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+541.0% upside
Current
$3.32
$3.32
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.47M | 21.55M | 19.28M |
| Net Income | -57,733,449 | 2.70M | 1.92M |
| Profit Margin | -2,336.5% | 12.5% | 10.0% |
| EBITDA | -45,089,418 | 4.73M | 4.55M |
| Free Cash Flow | — | 2.93M | 1.59M |
| Rev Growth | — | +2.0% | +3.7% |
| Debt/Equity | 1.42 | 0.67 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |